NextFin News - Santander has won a Court of Appeal ruling that wipes out a £677 million ($912 million) bill it faced over payment protection insurance mis-selling, in a judgment that shifts the cost of the scandal back onto French insurer AXA and shows how a single line of contract wording can outweigh two decades of commercial reality.
London's Court of Appeal on Tuesday overturned a High Court decision from July 2025 that had ordered the Spanish bank to reimburse AXA for redress costs tied to US store-card PPI policies. Judge Sara Cockerill held that the indemnity clause in a 2000 agency agreement covered acts or omissions occurring after the agreement took effect on December 1, 2000 — not liabilities arising from policies sold before that date. The court also dismissed AXA's cross-appeal seeking to recover some of its PPI compensation costs.
Santander welcomed the ruling and said AXA would now have to repay "the substantial majority of the amount" it had paid. Genworth's President and CEO Tom McInerney said the company was "very disappointed" by the ruling and would evaluate its next steps, including options for further appeals.
The Dispute: A 2000 Agency Agreement at the Centre of a £677 Million Fight
The case is a product of the serial reshuffling of legacy books that characterised the post-crisis decade. AXA inherited the PPI liabilities through its 2015 acquisition of two Genworth units. Santander, meanwhile, acquired GE Capital Bank — the entity that actually sold the insurance products — in 2009. Between them sat an agency agreement signed in 2000, under which Santander's predecessor sold PPI policies on AXA's behalf.
When the UK's PPI mis-selling scandal erupted, AXA paid out almost £500 million in redress to consumers and more than £70 million in related complaints-handling costs, according to the July 2025 High Court judgment. It then sought indemnity from Santander under the 2000 agreement. The High Court ruled in AXA's favour, awarding roughly £677 million including interest — a figure that, at the exchange rate cited in the appeal proceedings of $1 = £0.7421, translates to about $912 million.
Santander's appeal rested on a narrow but decisive distinction: the timing of the sales, not the timing of the losses. The bank argued that around 85% of the indemnity award — about £575 million including interest — related to policies sold before the agreement was signed, and that the High Court judge had wrongly given the clause retrospective effect. The Court of Appeal agreed, drawing a line between when a policy was sold and when a loss was incurred, and finding the indemnity protected only against conduct after December 1, 2000.
That construction is the more orthodox reading in English contract law. Courts are generally reluctant to give clauses retrospective effect unless the language clearly demands it, and the phrase "acts or omissions occurring after" points to the timing of the conduct rather than the timing of the loss. AXA's interpretation would have meant the indemnity responded to losses whenever they crystallised, even where the underlying sale predated the contract — a reading the appeal judges rejected.
The mechanics matter because they explain why the stakes were so asymmetric. For Santander, the appeal was about a contingent liability that had appeared on the wrong side of its balance sheet after a loss at first instance. For AXA and Genworth, it was about whether an acquisition made more than a decade earlier had come with the risk-transfer protection they had paid for. When legacy books change hands, the buyer is buying both the assets and the hidden time bombs; the indemnity is supposed to defuse them. This judgment says the defusal only works if the contract's words actually reach back far enough.
Why the Wording Beat the Fairness Argument
The judgment is a reminder that in indemnity disputes, the contract's text tends to prevail over what seems commercially sensible. AXA's position was not without merit, and it is worth stating the counter-argument in full before dismissing it.
AXA argued that the agreement covered future losses incurred after its commencement date, regardless of when the underlying policies were sold. The insurer also pointed out that Santander continued to receive about 95% of the premiums remaining after claims payments on the policies, regardless of when they were sold — making it, in AXA's view, commercially reasonable for the lender to bear responsibility for losses arising from its own sales practices. Santander countered that the High Court judge had relied too heavily on perceived commercial fairness rather than the contract's actual wording.
AXA argued that the agreement covered future losses incurred after its commencement date, regardless of when the underlying policies were sold, and that Santander continued to receive about 95% of the premiums remaining after claims payments on the policies, regardless of when they were sold.
The appeal court's decision effectively says that commercial fairness cannot rescue an interpretation the words do not support. That principle has teeth beyond this case. Legacy indemnities from the PPI era sit on the balance sheets of numerous banks and insurers, many of them struck in the rush of crisis-era disposals where the buyer explicitly priced in the recourse and the seller was keen to draw a line. If courts had endorsed AXA's fairness-first approach, every indemnity tied to legacy conduct would have become a live negotiation over who profited from the underlying business. By anchoring the analysis in the text, the judgment restores certainty — at the cost of leaving AXA with a bill it believed it had transferred.
The distinction that decided the case — "acts or omissions occurring after" a date versus "losses incurred after" a date — is the kind of drafting nuance that looks trivial in the boardroom and decisive in the courtroom. It will now be pored over by lawyers on both sides of every remaining PPI indemnity in the market, and by deal teams drafting the next legacy-book purchase. In that sense, the judgment's real value is not the £677 million it saves Santander; it is the precedent it sets for how the next legacy indemnity will be read.
The Bigger Picture: PPI's £50 Billion Shadow
The UK's PPI scandal remains the costliest mis-selling episode in British financial history, ultimately costing banks an estimated £50 billion in compensation. Most of that bill fell on the high-street lenders that sold the policies. But the Santander-AXA dispute shows how the fallout continued to ripple through the system years after the sales themselves, as liabilities were shuffled between owners through acquisitions and then re-litigated clause by clause.
The scandal's second act is already under way in motor finance, and the parallel is uncomfortable. Britain's financial regulator has been developing a compensation scheme for mis-sold car loans that industry participants and independent estimates place in a range of roughly £9 billion to £18 billion, with some industry sources floating figures as high as £18 billion to £20 billion depending on the methodology. Lenders including Santander UK have been building provisions against it: Santander UK lifted its motor-finance redress provision to £461 million in early 2026, up from £295 million, after the regulator's consultation on the scheme.
The motor-finance saga mirrors the PPI story in structure if not in scale: commission arrangements between lenders and dealers that regulators deemed unfair, redress costs that run into the billions, and a wave of litigation risk that sits between banks and insurers. The Cockerill judgment gives both sides of those future disputes a template for how the arguments will be framed. Banks will point to it as evidence that precise wording limits their exposure; claimants and insurers will point to the 95% premium-retention fact as evidence that commercial substance should still count. The difference is that the motor-finance provisions are being built now, while the PPI indemnities were drafted in 2000 — which means the wording battle for the next scandal has not yet been fought.
What the Win Is Worth to Santander
For Santander, the victory removes a contingent liability that had hung over the bank since the High Court ruling. The arithmetic is clear even if the accounting treatment is not: £677 million is roughly 0.36% of the group's market capitalisation of about €187 billion — material, but not transformative. The bigger value is the removal of uncertainty ahead of a year in which the bank is executing its largest expansion in a decade.
Santander is in an aggressive growth phase. It completed a £2.9 billion takeover of UK rival TSB in May 2026, bringing the combined UK franchise close to 28 million customers and making it the third-biggest bank for current accounts in Britain. It has agreed to buy US regional lender Webster Financial for about $12.2 billion, a cash-and-stock transaction expected to close in the second half of 2026 that would create one of the ten largest retail and commercial banks in the US by assets, with a combined US balance sheet of approximately $327 billion. Management has said the deal would put the US unit on track for a return on tangible equity of about 18% by 2028, supporting a group-level target above 20%.
A £677 million charge would have dented that trajectory; its removal is a clean earnings tailwind. The shares themselves barely reacted, trading 0.44% lower at €12.716 in Madrid on the day of the ruling — a sign that investors had already assigned a meaningful probability to success, and that the headline figure is small relative to the equity value. Markets price outcomes, not headlines, and in this case the outcome was largely anticipated. The muted move also reflects the fact that Santander had likely already provisioned for at least part of the exposure, so the accounting benefit of the win may be smaller than the headline suggests.
There is also a strategic dimension. Santander's UK franchise has been a persistent drag on group returns, and the TSB integration is meant to fix that. Walking away from a £677 million legacy charge frees capital and management attention for that integration rather than for litigation. It also strengthens the bank's hand in any future negotiations over conduct legacies: it has shown it is willing to litigate indemnities to the Court of Appeal and win. For a bank that has spent years trying to convince investors that its UK operations can be a source of strength rather than a sink for capital, the timing is useful.
For AXA and Genworth, a Reopened Wound
For AXA and Genworth, the reversal is a fresh blow. AXA inherited the liabilities as part of its 2015 Genworth deal, pricing them on the assumption that it had contractual recourse to Santander. Genworth — now under new ownership and led by McInerney — had been working through the run-off of those legacy books, and the Court of Appeal's dismissal of AXA's cross-appeal closes off one route to recovery.
McInerney's statement that the company is evaluating "options for further appeals" leaves the door ajar for a Supreme Court challenge. That is a real risk for Santander. If the Supreme Court were to take the case and reverse the Court of Appeal, the £677 million liability — plus years of accrued interest — would return to Santander's balance sheet. The bank's confidence that AXA must repay "the substantial majority" of what was paid is understandable, but the file is not closed until the permission window passes.
There is a broader lesson here for insurers buying legacy books. AXA's 2015 Genworth acquisition was a deliberate bet on the US protection and mortgage insurance market, but it came with run-off liabilities that were difficult to price precisely. The PPI indemnity was supposed to be one of the hedges against that uncertainty. Losing it in court means the acquisition's risk profile was worse than modelled — a reminder that in legacy-book deals, the due diligence that matters most is the legal due diligence on the contracts, not just the actuarial due diligence on the liabilities.
Counter-Thesis: Is This Really a Win for Banks?
The strongest argument against reading this as a broad victory for banks is that it is highly fact-specific. The outcome turned on the particular wording of a 2000 agency agreement and the unusual structure of a sale in which the seller retained most of the premium stream. Most PPI indemnities were drafted in the heat of transactions where the buyer explicitly priced in the recourse, and many are worded around "claims made" or "losses incurred" triggers that would not be affected by this ruling. A single Court of Appeal decision on one contract does not rewrite the law of indemnity, and banks with differently drafted clauses should not assume they can replicate Santander's escape.
There is also a reputational dimension that the numbers do not capture. Santander's win rests on a technicality that allows it to walk away from costs linked to its own predecessor's sales practices — a framing that claimant groups and politicians may find difficult to accept, even if it is legally sound. In an environment where regulators are already scrutinising banks' conduct legacies, a technical escape from responsibility could invite closer supervisory attention elsewhere. The court of law and the court of public opinion apply different standards, and banks rarely win both on the same day.
Finally, the win is conditional on no further appeal succeeding. Genworth has said it is considering further appeals, and the Supreme Court route remains open. For a contingent liability to be truly removed, it must survive not just one court but every court that agrees to hear the case. Santander's victory is real, but it is a victory at one level of a multi-level judicial system, not the end of the road.
What to Watch
In the short term, the key signal is whether Genworth or AXA files for permission to appeal to the Supreme Court within the standard window — such a filing would reopen the uncertainty and force Santander to reconsider any accounting benefit it has taken. Over the medium term, watch whether other banks with legacy PPI indemnities cite the Cockerill judgment in their own disputes; if similar "acts or omissions" clauses appear across the market, the ruling could unlock billions in avoided costs. Over the longer term, the structural question is whether acquirers of legacy insurance books will continue to rely on indemnities as risk transfer, or whether this judgment pushes them toward pricing the risk directly into the purchase consideration — which would make legacy-book deals more expensive and less attractive.
Bottom line: Santander's appeal win is a victory for contractual precision over commercial intuition — but until the Supreme Court door closes, the £677 million question is deferred, not answered.
Explore more exclusive insights at nextfin.ai.
